Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Sanofi Pasteur, a Sanofi Company

Conditions

DiphtheriaMeningitisMeningococcal DiseasePertussisTetanus

Phase 1

Pertussis Vaccine in Healthy Pregnant Women

CompletedNCT00707148

National Institute of Allergy and Infectious Diseases (NIAID)Diphtheria, Pertussis, Tetanus

Start: 2009-01-31End: 2012-05-31Updated: 2014-07-25

Phase 3

Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea

CompletedNCT01642589

Sanofi Pasteur, a Sanofi CompanyMeningitis, Meningococcal Disease

Start: 2012-07-31End: 2013-06-30Updated: 2013-12-03

Related Papers

Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants

JAMA2014-05-03482 citations